Get the Stockscreener App
78.19
0.53%
-0.42
Livanova Plc stock is traded at $78.19, with a volume of 412.29K.
It is down -0.53% in the last 24 hours and down -2.20% over the past month.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
See More
Previous Close:
$78.61
Open:
$79.61
24h Volume:
412.29K
Relative Volume:
0.54
Market Cap:
$4.30B
Revenue:
$1.43B
Net Income/Loss:
$107.13M
P/E Ratio:
40.36
EPS:
1.9372
Net Cash Flow:
$161.04M
1W Performance:
-3.11%
1M Performance:
-2.20%
6M Performance:
+23.80%
1Y Performance:
+80.62%
1-Day Range:
$77.86
$79.73
1-Week Range:
$75.30
$80.92
52-Week Range:
$41.02
$85.27
Livanova Plc Stock (LIVN) Company Profile
Name
Livanova Plc
Sector
Industry
Phone
4402033250662
Address
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
78.19 | 4.30B | 1.43B | 107.13M | 161.04M | 1.9372 |
ABT
Abbott Laboratories
|
103.06 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.25 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.21 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
44.25 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.63 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-25 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-01-25 | Downgrade | Goldman | Buy → Neutral |
| May-20-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Feb-26-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-04-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-20-24 | Reiterated | Needham | Buy |
| Feb-20-24 | Upgrade | Mizuho | Neutral → Buy |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-14-23 | Initiated | Mizuho | Neutral |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Feb-24-22 | Upgrade | UBS | Neutral → Buy |
| Dec-03-21 | Initiated | Goldman | Buy |
| Aug-20-21 | Reiterated | Needham | Buy |
| Jul-20-21 | Upgrade | Needham | Hold → Buy |
| Mar-03-21 | Downgrade | Berenberg | Buy → Hold |
| Jan-05-21 | Downgrade | Needham | Buy → Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Jun-26-20 | Reiterated | Needham | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-08-18 | Initiated | Stifel | Buy |
| May-31-18 | Reiterated | Needham | Buy |
| Feb-28-18 | Reiterated | Needham | Buy |
View All
Livanova Plc Stock (LIVN) Latest News
LivaNova PLC (LIVN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
LIVN|LivaNova PLC|Price:78.190|Chg%:-0.420 - TradingKey
LivaNova PLC Revenue Breakdown – NASDAQ:LIVN - TradingView
LivaNova PLC (LIVN) Stock Forecasts - Yahoo Finance
LIVN6033156 Bond Coupon Profile — Rate & Payments - TradingView
LIVN6033156 Bond Risk Profile - TradingView
LIVN6033156 Bond Profile — Key Metrics - TradingView
LivaNova (NASDAQ:LIVN) Fits the Affordable Growth Profile with Strong Earnings and Relative Value - ChartMill
(LIVN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
LivaNova PLC at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Q1 2020 LivaNova PLC Earnings Call Transcript - GuruFocus
Q3 2025 LivaNova PLC Earnings Call Transcript - GuruFocus
Q1 2025 LivaNova PLC Earnings Call Transcript - GuruFocus
LivaNova PLC (BSP:L2IV34) Stock Price, Trades & News - GuruFocus
LivaNova PLC (BSP:L2IV34)Valuation Measures & Financial Statistics - GuruFocus
LivaNova PLC (BSP:L2IV34) Stock Earnings Transcripts - GuruFocus
BSP:L2IV34 Equity-to-Asset: 0.48 — 11% Below Median - GuruFocus
LivaNova PLC Stock Operating Data - GuruFocus
BSP:L2IV34 Dividend: Does LivaNova PLC Pay a Dividend? - GuruFocus
LivaNova PLC (BSP:L2IV34) DCF Valuation - GuruFocus
LivaNova PLC Stock Warning Signs - GuruFocus
Jette Nygaard-Andersen joins LivaNova board as a new director - MSN
LIVN Maintains by Mizuho -- Price Target Raised to $95.00 - GuruFocus
LivaNova PLC (LIVN) Shares Fall 4.7% -- GF Value Says Still Over - GuruFocus
3 Service Sector Stocks With Pricing Power Investors Should Watch - Sahm
LivaNova appoints Anne Liddy as chief legal officer - MSN
LivaNova Q1 2026 Earnings: EPS Surpasses Estimates by 7.14% Amidst Mixed Market ReactionGross Profit Margin - dars.gov.et
World Cardiopulmonary Bypass MachineMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Price to earnings forward of LivaNova Plc – SWB:LIA - TradingView
Price to sales forward of LivaNova PLC – NASDAQ:LIVN - TradingView
LivaNova PLC balances neuromodulation growth with cardiac surgery challenges - AD HOC NEWS
Enterprise value to EBITDA forward of LivaNova PLC – NASDAQ:LIVN - TradingView
LivaNova PLC (LIVN) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
LivaNova PLC focuses on neuromodulation and cardiopulmonary solutions as investors track its Nasdaq- - AD HOC NEWS
Enterprise value to revenue forward of LivaNova PLC – NASDAQ:LIVN - TradingView
Price to sales forward of LivaNova Plc – LSX:A14156 - TradingView
How LivaNova’s Broad Russell Index Inclusion Will Impact LivaNova (LIVN) Investors - simplywall.st
Price to book forward of LivaNova PLC – NASDAQ:LIVN - TradingView
LivaNova Stock Sinks After Key Sleep Trial Fails - TipRanks
LivaNova stock hits 52-week high at 84.3 USD By Investing.com - Investing.com Nigeria
LivaNova stock hits 52-week high at 84.3 USD - Investing.com
LivaNova (LIVN) Shows Modest Uptick as Stock Tests Key Resistance Near $87Gamma Flip Level - dars.gov.et
LivaNova PLC (LIVN) Q1 2026 Earnings: EPS Surges Past Estimates Despite Missing Revenue DetailsConsensus Forecast Report - dars.gov.et
LivaNova PLC Q1 2026 Earnings: EPS Surpasses Estimates, Stock Edges HigherPeak Earnings Alert - dars.gov.et
LivaNova Plc Change Of Registered Office - marketscreener.com
Analysts initiate coverage on Abbott, LivaNova, Amplitude, Lionsgate, Honeywell - scanx.trade
Livanova stock initiated at Hold by Freedom Capital on growth outlook - Investing.com Nigeria
LivaNova Shares Positive 12-Month Results From Obstructive Sleep Apnea Study - Medical Product Outsourcing
LivaNova PLC(NasdaqGS: LIVN) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
LivaNova PLC(NasdaqGS: LIVN) added to Russell 2500 Growth Benchmark - marketscreener.com
LivaNova PLC(NasdaqGS: LIVN) added to Russell 2000 Growth Benchmark - marketscreener.com
Livanova Plc Stock (LIVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Livanova Plc Stock (LIVN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SCHERMERHORN TODD C | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
13,105 |
| Bianchi Francesco | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
11,270 |
| Bianchi Francesco | Director |
Jun 15 '26 |
Sale |
80.19 |
1,200 |
96,228 |
9,584 |
| PODLOGAR SUSAN M | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
6,128 |
| Barry James Christopher | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
8,404 |
| Tezel Ahmet | Chief Innovation Officer |
Jun 15 '26 |
Option Exercise |
0.00 |
2,965 |
0 |
7,122 |
| KOZY WILLIAM A | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
5,681 |
0 |
38,248 |
| Enxing Seng Stacy | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
15,793 |
| Story Brooke | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
10,274 |
| Zurbay Donald | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
2,560 |
0 |
2,560 |
1.90%
2.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):